Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial

Peer Review reports

Original Submission
17 Apr 2021	Submitted	Original manuscript
1 Sep 2021	Reviewed	Reviewer Report - Alexander Gough
28 Sep 2021	Reviewed	Reviewer Report - Francico-Javier Gonzalez-Barcala
19 Oct 2021	Reviewed	Reviewer Report - Michael Abel Alao
28 Dec 2021	Author responded	Author comments - Qing Kong
Resubmission - Version 2
28 Dec 2021	Submitted	Manuscript version 2
29 Dec 2021	Reviewed	Reviewer Report - Francico-Javier Gonzalez-Barcala
6 Jan 2022	Reviewed	Reviewer Report - Alexander Gough
20 Jan 2022	Author responded	Author comments - Qing Kong
Resubmission - Version 3
20 Jan 2022	Submitted	Manuscript version 3
24 Jan 2022	Reviewed	Reviewer Report - Alexander Gough
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
27 Jan 2022	Editorially accepted
14 Feb 2022	Article published	10.1186/s13063-022-06057-7

Back to article page